Expert Perspectives on Biosimilar Agents
  • Program Overview
    Expert Perspectives on Biosimilar Agents
    This in-depth educational program, which features a video module, downloadable slideset with slidenotes, and a series of ClinicalThought commentaries, illuminates expert perspectives on biosimilars with a specific emphasis on their application in the oncology, rheumatology, and gastroenterology specialites.
  • Featured content
    As biosimilars penetrate the GI treatment space, here’s my take on what gastroenterologists need to know.
    Date Posted: 12/6/2017
  • Featured content
    In this video module, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
  • Featured content
    In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Date Posted: 11/16/2017
  • 1
  • 2
  • 3
  • 4

Latest Content

4 of 4 Shown
  • My Take: Addressing Patient Reluctance to Switch From an Originator to Its Biosimilar for Treatment of Rheumatic Disease

    Jonathan Kay MD - 2/13/2018
    Despite demonstration of comparable efficacy and safety between biosimilars and their originators, some patients avoid this treatment switch. Here’s my take on steps to assuage unfounded patient fears.
  • My Take: Navigating Biosimilars for IBD

    Russell D. Cohen MD, FACG, AGAF - 12/6/2017 2 comments / Last Comment: 1/26/2018
    As biosimilars penetrate the GI treatment space, here’s my take on what gastroenterologists need to know.
  • Video Module cme-icon

    Expert Perspectives on Biosimilar Agents

    In this video module, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Faculty: Andrew M. Evens DO, MSc, FACP, Jonathan Kay MD, Alan C. Moss MD
    Released: 11/16/2017
  • Expert Perspectives on Biosimilar Agents

    In these downloadable slides, a multidisciplinary panel of expert faculty discuss the use of biosimilars across oncology, rheumatology, dermatology, and gastroenterology specialties.
    Date Posted: 11/16/2017
4 of 4 Shown
Show 0 More
Loading...